Inactive Instrument
Acusphere, Inc. Stock Other OTC
Stocks
US00511R8705
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Other OTC
|
||
| - USD | - |
|
| 13-11-06 | Acusphere Appoints William Ramage as Chief Development Officer | CI |
| 13-10-21 | Acusphere, Inc. has Changed its Ticker to ACUS from ACUSD | CI |
| Market Cap | 3.46M 2.99M 2.83M 2.56M 4.8M 331M 4.84M 33.57M 12.91M 168M 13.01M 12.73M 532M | P/E 2006 |
-1.06x | P/E 2007 | -0.49x |
|---|---|---|---|---|---|
| Enterprise Value | -11.29M -9.74M -9.23M -8.35M -15.66M -1.08B -15.78M -109M -42.09M -549M -42.39M -41.47M -1.74B | EV / Sales 2006 |
9,811,030x | EV / Sales 2007 | 5,744,305x |
| Free-Float |
100% | Yield 2006 * |
-
| Yield 2007 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.13% | -3.11% | +13.82% | +60.66% | 46.21B | ||
| -1.13% | -5.78% | +33.26% | +108.13% | 38.78B | ||
| +0.12% | -0.08% | +7.12% | +78.27% | 11.68B | ||
| -0.53% | -1.37% | -13.25% | +10.18% | 11.55B | ||
| -0.38% | -2.26% | +18.18% | +139.63% | 9.14B | ||
| +0.32% | -2.26% | +23.08% | +34.73% | 7.3B | ||
| +0.17% | -0.74% | +13.44% | +197.13% | 7.15B | ||
| -1.00% | -5.25% | +34.34% | -19.63% | 7.1B | ||
| -3.13% | -4.30% | -44.88% | +11.66% | 4.97B | ||
| Average | -0.74% | -2.59% | +9.46% | +68.97% | 15.99B | |
| Weighted average by Cap. | -0.86% | -3.27% | +16.06% | +75.66% |
| 2006 | 2007 | |
|---|---|---|
| Net sales | 1.78 1.54 1.46 1.32 2.47 170.16 2.49 17.25 6.64 86.55 6.69 6.54 273.63 | 2.67 2.3 2.18 1.97 3.7 254.81 3.73 25.84 9.94 129.6 10.01 9.79 409.75 |
| Net income | -61.09M -52.71M -49.91M -45.18M -84.71M -5.84B -85.34M -592M -228M -2.97B -229M -224M -9.39B | -53.73M -46.36M -43.9M -39.74M -74.5M -5.13B -75.06M -521M -200M -2.61B -202M -197M -8.25B |
| Net Debt | -52.87M -45.62M -43.2M -39.11M -73.32M -5.05B -73.86M -512M -197M -2.57B -198M -194M -8.12B | -14.76M -12.73M -12.06M -10.92M -20.46M -1.41B -20.62M -143M -55M -717M -55.4M -54.2M -2.27B |
Employees
-
Sector
Pharmaceuticals
Select your edition
All financial news and data tailored to specific country editions
















